Document is current
Any future updates will be listed below
-
Authors
Sheth, Kevin N.
Yuen, Matthew M.
Mazurek, Mercy H.
Cahn, Bradley A.
Prabhat, Anjali M.
Salehi, Sadegh
Shah, Jill T.
By, Samantha
Welch, E. Brian
Sofka, Michal
Sacolick, Laura I.
Kim, Jennifer A.
Payabvash, Seyedmehdi
Falcone, Guido J.
Gilmore, Emily J.
Hwang, David Y.
Matouk, Charles
Gordon-Kundu, Barbara
RN, Adrienne Ward
Petersen, Nils
Schindler, Joseph
Gobeske, Kevin T.
Sansing, Lauren H.
Sze, Gordon
Rosen, Matthew S.
Kimberly, W. Taylor
Kundu, Prantik
-
Funding
Funding for this research was provided by:
American Heart Association (17CSA3355004, 17CSA3355004, 17CSA3355004)
Hyperfine Inc.
- License Information
-
More Information
Article History
Received: 29 March 2021
Accepted: 2 December 2021
First Online: 7 January 2022
Competing interests
: KNS is the principal investigator, and this study received support from the Collaborative Science Award from the American Heart Association (Co-PIs: KNS, WTK, and MSR) and from a Hyperfine, Inc. research grant. WTK receives grants from NIH and AHA; grants and personal fees from Biogen, Inc; grants and personal fees from NControl Therapeutics; has a patent pending that is licensed to NControl Therapeutics; holds equity in Woolsey Pharmaceuticals. MSR is a founder and equity holder of Hyperfine, Inc. LS, MS, SS, PK, SB, EBW are employed by Hyperfine, Inc. The other authors declare no competing interests.
